Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel.
暂无分享,去创建一个
J. Au | M. Wientjes | Danny Chen | D. Song
[1] J. Drago,et al. A Method to Study Drug Concentration–Depth Profiles in Tissues: Mitomycin C in Dog Bladder Wall , 1991, Pharmaceutical Research.
[2] Antonius A. Miller,et al. Taxol and taxotere in bladder cancer: in vitro activity and urine stability , 2004, Cancer Chemotherapy and Pharmacology.
[3] H. Hashimoto,et al. Dimethylsulfoxide enhances the absorption of chemotherapeutic drug instilled into the bladder , 2004, Urological Research.
[4] J. Chin,et al. Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. , 2001, Journal of the National Cancer Institute.
[5] J. Guignard,et al. The Effects of Dimethyl Sulfoxide on Renal Function of the Newborn Rabbit , 1999, Neonatology.
[6] J. Au,et al. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment , 1999, Cancer Chemotherapy and Pharmacology.
[7] R. Badalament,et al. Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] M. Guillaume Wientjes,et al. Bladder tissue pharmacokinetics of intravesical taxol , 1997, Cancer Chemotherapy and Pharmacology.
[9] Jessie L.-S. Au,et al. Pharmacologic effects of paclitaxel in human bladder tumors , 1997, Cancer Chemotherapy and Pharmacology.
[10] B. Roth. Preliminary experience with paclitaxel in advanced bladder cancer. , 1995, Seminars in oncology.
[11] J. Au,et al. Isocratic high-performance liquid chromatographic assay of taxol in biological fluids and tissues using automated column switching. , 1995, Journal of chromatography. B, Biomedical applications.
[12] R. Badalament,et al. Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patients. , 1994, The Journal of urology.
[13] A. C. Dubbelman,et al. Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Badalament,et al. Penetration of mitomycin C in human bladder. , 1993, Cancer research.
[15] W. See,et al. Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity. , 1992, Journal of the National Cancer Institute.
[16] J. Drago,et al. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. , 1991, Cancer research.
[17] J. Drago,et al. Bladder wall penetration of intravesical mitomycin C in dogs. , 1991, Cancer research.
[18] Herrmann Hw. Intravesical therapy. A critical review. , 1987 .
[19] H. Herr. Intravesical therapy. A critical review. , 1987, The Urologic clinics of North America.
[20] S. Jacob,et al. Pharmacology of DMSO. , 1986, Cryobiology.
[21] S. Insalaco,et al. The effect of dimethyl sulfoxide on the uptake of cisplatin from the urinary bladder of the dog: a pilot study. , 1983, The Journal of the American Osteopathic Association.
[22] B. Berne,et al. Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics , 1976 .
[23] D. Wood,et al. PHARMACOLOGIC AND BIOCHEMICAL CONSIDERATIONS OF DIMETHYL SULFOXIDE , 1975, Annals of the New York Academy of Sciences.
[24] B. Ketterer,et al. The ultrastructure and chemistry of the luminal plasma membrane of the mammalian urinary bladder: a structure with low permeability to water and ions. , 1974, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[25] Turnbull Gj. Ultrastructural basis of the permeability barrier in urothelium. , 1973 .
[26] G. J. Turnbull. Ultrastructural basis of the permeability barrier in urothelium. , 1973, Investigative urology.